News - Pharmaceutical
GW Pharmaceuticals expects approval for MS drug derived from cannabis
18 March 2010
GW Pharmaceuticals, which makes drugs derived from cannabis, is due to have its first medicine on the market within months. The British biotech company ...
Click on the link to read the full article at Times Online (This link will open in a new window)Pharmaceutical Company Settles Whistleblower's Lawsuit
18 March 2010
The pharmaceutical company Alpharma has agreed to a legal settlement to pay $42.5 million in response to allegations that it paid doctors to promote and ...
Click on the link to read the full article at Avvo (This link will open in a new window)Factbox: Teva Pharmaceutical's history of acquisitions
18 March 2010
In August 1999, Teva bought Massachusetts-based Copley Pharmaceutical Inc, a maker of generic and branded drugs, for $220 million.
Click on the link to read the full article at Reuters (This link will open in a new window)Grace Earns Quality Certification for Pharmaceutical Manufacturing
18 March 2010
The certification is a verification that Grace's Quality Management System meets the requirements of the Joint International Pharmaceutical Excipients ...
Click on the link to read the full article at MarketWatch (press release) (This link will open in a new window)Otsuka Pharmaceutical drug fast-tracked by FDA
18 March 2010
Otsuka Pharmaceutical has received fast-track designation from the Food and Drug Administration (FDA) for a new treatment for dry age-related macular ...
Click on the link to read the full article at Zenopa (This link will open in a new window)Teva to wait for appeals court verdict on Temodar
17 March 2010
March 17 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA) (TEVA.O) said it agreed with parties in a patent lawsuit regarding a copycat of Merck ...
Click on the link to read the full article at Reuters (This link will open in a new window)King Pharmaceuticals Announces US Department of Justice Settlement
17 March 2010
The investigation related to Alpharma's sales and marketing of the pharmaceutical product Kadian® (morphine sulfate extended-release) Capsules prior to ...
Click on the link to read the full article at CNNMoney.com (press release) (This link will open in a new window)MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for ...
17 March 2010
IncreaseRx(R) utilizes a suite of traditional and web-based tactics to generate incremental revenue for any pharmaceutical brand regardless of product life ...
Click on the link to read the full article at MarketWatch (press release) (This link will open in a new window)Stellar Pharmaceuticals Profitable for 2009
17 March 2010
Stellar Pharmaceuticals Inc. (OTCBB: SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective ...
Click on the link to read the full article at CNNMoney.com (press release) (This link will open in a new window)BioTech Market Watch for Angiotech Pharmaceuticals Inc. Issued by StockPreacher
17 March 2010
ANPI operates in two segments: Pharmaceutical Technologies and Medical Products. "Boston Scientific Corp. recently announced results from an analysis of ...
Click on the link to read the full article at CNNMoney.com (press release) (This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
